We are live on ! Find out more
RP

Riverbridge Partners Portfolio holdings

AUM $3.58B
1-Year Est. Return 4.02%
This Fund
S&P 500
This Quarter Est. Return
+10.87%
1 Year Est. Return
+4.02%
3 Year Est. Return
+40.43%
5 Year Est. Return
+44.7%
10 Year Est. Return
+473.33%
AUM
$5.38B
AUM Growth
+$250M
Cap. Flow
-$232M
Cap. Flow %
-4.31%
Top 10 Hldgs %
29.56%
Holding
133
New
6
Increased
36
Reduced
78
Closed
5

Sector Composition

Rank Sector Weight
1 Technology 23.66%
2 Industrials 20.37%
3 Healthcare 17.97%
4 Consumer Discretionary 11.71%
5 Consumer Staples 5.55%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CPHD
1
DELISTED
Cepheid Inc
CPHD
$247M 4.6%
4,568,086
-148,879
-3% -$7.53M
ULTI
2
DELISTED
Ultimate Software Group Inc
ULTI
$175M 3.25%
1,190,301
-10,415
-0.9% -$1.51M
RBA icon
3
RB Global
RBA
$21.5B
$163M 3.03%
6,052,405
-232,981
-4% -$5.78M
CSGP icon
4
CoStar Group
CSGP
$12B
$156M 2.9%
8,490,700
+563,850
+7% +$9.11M
ATHN
5
DELISTED
Athenahealth, Inc.
ATHN
$152M 2.83%
1,043,467
-36,857
-3% -$4.63M
GNTX icon
6
Gentex
GNTX
$5.17B
$150M 2.79%
8,297,964
-128,218
-2% -$2.13M
NATI
7
DELISTED
National Instruments Corp
NATI
$148M 2.75%
4,758,184
-156,019
-3% -$4.84M
UNFI icon
8
United Natural Foods
UNFI
$3.06B
$142M 2.64%
1,833,376
-62,168
-3% -$4.4M
PRAA icon
9
PRA Group
PRAA
$678M
$132M 2.46%
2,280,715
-40,149
-2% -$2.37M
ROL icon
10
Rollins
ROL
$18.9B
$126M 2.34%
12,841,338
-468,477
-4% -$4.38M
MD icon
11
Pediatrix Medical
MD
$2.18B
$123M 2.28%
1,853,884
-541,150
-23% -$33M
ABCO
12
DELISTED
Advisory Board Co
ABCO
$121M 2.24%
2,461,368
-165,333
-6% -$7.78M
MMS icon
13
Maximus
MMS
$3.34B
$116M 2.16%
2,114,587
-877,790
-29% -$42.7M
PRLB icon
14
Protolabs
PRLB
$1.72B
$115M 2.14%
1,710,971
+341,100
+25% +$22.4M
NEOG icon
15
Neogen
NEOG
$1.98B
$114M 2.12%
6,123,752
-358,853
-6% -$5.9M
CHE icon
16
Chemed
CHE
$7.17B
$107M 1.99%
1,011,370
-33,802
-3% -$3.57M
TRAK
17
DELISTED
DEALERTRACK TECHNOLOGIES, INC. COM STK
TRAK
$107M 1.98%
2,404,573
-94,347
-4% -$4.2M
BECN
18
DELISTED
Beacon Roofing Supply, Inc.
BECN
$106M 1.97%
3,804,617
+675,768
+22% +$18.3M
LOPE icon
19
Grand Canyon Education
LOPE
$4.16B
$106M 1.96%
2,262,308
-62,731
-3% -$2.8M
SRCL
20
DELISTED
Stericycle Inc
SRCL
$96.7M 1.8%
737,791
-9,375
-1% -$1.18M
LKQ icon
21
LKQ Corp
LKQ
$6.74B
$94M 1.75%
3,343,090
-63,669
-2% -$1.78M
HCSG icon
22
Healthcare Services Group
HCSG
$1.58B
$92.4M 1.72%
2,987,072
-11,814
-0.4% -$350K
LLTC
23
DELISTED
Linear Technology Corp
LLTC
$83.2M 1.55%
1,824,634
-28,243
-2% -$1.23M
IPCM
24
DELISTED
IPC HEALTHCARE INC COM DTD
IPCM
$82.4M 1.53%
1,795,291
-72,365
-4% -$3.15M
MINI
25
DELISTED
Mobile Mini Inc
MINI
$78.3M 1.46%
1,932,557
-339,538
-15% -$13.7M

Similar funds

Riverbridge Partners's Q4 2014 Portfolio in Review

As of Q4 2014, Riverbridge Partners held 133 positions worth $5.38B, up 4.9% from $5.13B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Riverbridge Partners withdrew a net $232M in Q4 2014, closing 5 positions and reducing 78 holdings. Its most notable exit was CONCUR TECHNOLOGIES INC, an estimated $71.2M position sold in full.

By sector, the portfolio is most concentrated in Technology at 24% of assets, down from 24% a quarter earlier, followed by Industrials and Healthcare.

Against the trend, Riverbridge Partners opened a new position in EXAMWORKS GROUP INC COM STK (DE) worth $44.6M.

  • Riverbridge Partners's largest Q4 2014 buy was EXAMWORKS GROUP INC COM STK (DE): 1,072,196 shares worth $44.6M.
  • Riverbridge Partners added most to Protolabs in Q4 2014, an estimated $22.4M increase.
  • Riverbridge Partners's biggest Q4 2014 reduction was ROCKWOOD HLDGS INC, cutting an estimated $44.7M.
  • Riverbridge Partners fully exited CONCUR TECHNOLOGIES INC in Q4 2014, selling an estimated $71.2M.
  • Riverbridge Partners's ten largest holdings make up 30% of its $5.38B portfolio in Q4 2014.
  • Riverbridge Partners opened 6 new positions and closed 5 in Q4 2014.
  • Riverbridge Partners's portfolio value rose 4.9% quarter-over-quarter to $5.38B.

Based on Riverbridge Partners's 13F filing for Q4 2014, filed 20 Jan 2015.